indobufen has been researched along with Intermittent Claudication in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 6 (75.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albuquerque, P; Baitsch, G; Gomez Alonso, A; Ibanez, F; Kester, RC; Leveson, S; Poredos, P; Tönnesen, KH | 1 |
Celi, V; Chello, M; Colonna, A; Marchese, AR; Mastroroberto, P; Romano, F | 1 |
Dobrovolsky, A; Eshkeeva, A; Hussain, KM; Karpov, Yu; Panchenko, E; Podinovskaya, Ya; Titaeva, E | 1 |
Costa, F; Rossini, A; Tascino, C | 1 |
Bhana, N; McClellan, KJ | 1 |
Astara, C; Binaghi, F; Carboni, MR; Fronteddu, PF; Onnis, A | 1 |
Belcaro, G; De Simone, P | 1 |
Maraglino, G; Salmistraro, G; Signorini, GP | 1 |
1 review(s) available for indobufen and Intermittent Claudication
Article | Year |
---|---|
Indobufen: an updated review of its use in the management of atherothrombosis.
Topics: Aged; Atrial Fibrillation; Clinical Trials as Topic; Coronary Artery Bypass; Humans; Intermittent Claudication; Isoindoles; Phenylbutyrates; Platelet Aggregation Inhibitors; Thromboembolism | 2001 |
6 trial(s) available for indobufen and Intermittent Claudication
Article | Year |
---|---|
Double-blind, controlled, multicenter study of indobufen versus placebo in patients with intermittent claudication.
Topics: Double-Blind Method; Female; Follow-Up Studies; Humans; Intermittent Claudication; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Time Factors | 1993 |
Reduction by indobufen of neutrophil activation in peripheral arterial occlusive disease.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Arterial Occlusive Diseases; Cyclooxygenase Inhibitors; Humans; Intermittent Claudication; Isoindoles; Lactic Acid; Middle Aged; Neutrophil Activation; Phenylbutyrates; Platelet Aggregation Inhibitors; Thromboxane B2 | 1996 |
Effects of indobufen and pentoxifylline on walking capacity and hemostasis in patients with intermittent claudication: results of six months of treatment.
Topics: beta-Thromboglobulin; Fibrinogen; Hemostasis; Humans; Intermittent Claudication; Isoindoles; Middle Aged; Pentoxifylline; Phenylbutyrates; Platelet Aggregation Inhibitors; Treatment Outcome; Vasodilator Agents; Walking | 1997 |
[Heparan sulphate in association with indobufen in the treatment of chronic peripheral obliterative arteriopathy of the lower extremities. Controlled clinical trial].
Topics: Adult; Aged; Arterial Occlusive Diseases; Female; Heparitin Sulfate; Humans; Intermittent Claudication; Isoindoles; Leg; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors | 1998 |
Long-term evaluation of indobufen in peripheral vascular disease.
Topics: Aspirin; Diabetes Complications; Female; Humans; Intermittent Claudication; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Walking | 1991 |
Efficacy of indobufen in the treatment of intermittent claudication.
Topics: Clinical Trials as Topic; Humans; Intermittent Claudication; Isoindoles; Oscillometry; Phenylbutyrates; Plethysmography | 1988 |
1 other study(ies) available for indobufen and Intermittent Claudication
Article | Year |
---|---|
[Effects of physical exercise and indobufen in patients with intermittent claudication. Results after a 2-year follow-up].
Topics: Aged; Exercise Test; Follow-Up Studies; Humans; Intermittent Claudication; Isoindoles; Male; Middle Aged; Phenylbutyrates; Physical Exertion; Platelet Aggregation Inhibitors; Time Factors | 1991 |